Bide Pharmatech Co., Ltd. (SHA:688073)
China
· Delayed Price · Currency is CNY 43.79
-0.52 (-1.17%)
At close: May 30, 2025, 2:57 PM CST
Bide Pharmatech Revenue
Bide Pharmatech had revenue of 296.37M CNY in the quarter ending March 31, 2025, with 12.83% growth. This brings the company's revenue in the last twelve months to 1.14B, up 3.05% year-over-year. In the year 2024, Bide Pharmatech had annual revenue of 1.10B with 0.93% growth.
Revenue (ttm)
1.14B
Revenue Growth
+3.05%
P/S Ratio
3.38
Revenue / Employee
1.54M
Employees
738
Market Cap
3.84B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |